IBDEI2FZ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39007,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,39007,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,39007,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,39008,0)
 ;;=L50.9^^152^1990^326
 ;;^UTILITY(U,$J,358.3,39008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39008,1,3,0)
 ;;=3^Urticaria,Unspec
 ;;^UTILITY(U,$J,358.3,39008,1,4,0)
 ;;=4^L50.9
 ;;^UTILITY(U,$J,358.3,39008,2)
 ;;=^5009204
 ;;^UTILITY(U,$J,358.3,39009,0)
 ;;=L53.8^^152^1990^150
 ;;^UTILITY(U,$J,358.3,39009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39009,1,3,0)
 ;;=3^Erythematous Conditions NEC
 ;;^UTILITY(U,$J,358.3,39009,1,4,0)
 ;;=4^L53.8
 ;;^UTILITY(U,$J,358.3,39009,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,39010,0)
 ;;=L53.9^^152^1990^149
 ;;^UTILITY(U,$J,358.3,39010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39010,1,3,0)
 ;;=3^Erythematous Condition,Unspec
 ;;^UTILITY(U,$J,358.3,39010,1,4,0)
 ;;=4^L53.9
 ;;^UTILITY(U,$J,358.3,39010,2)
 ;;=^5009210
 ;;^UTILITY(U,$J,358.3,39011,0)
 ;;=L54.^^152^1990^148
 ;;^UTILITY(U,$J,358.3,39011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39011,1,3,0)
 ;;=3^Erythema in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,39011,1,4,0)
 ;;=4^L54.
 ;;^UTILITY(U,$J,358.3,39011,2)
 ;;=^5009211
 ;;^UTILITY(U,$J,358.3,39012,0)
 ;;=L56.0^^152^1990^142
 ;;^UTILITY(U,$J,358.3,39012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39012,1,3,0)
 ;;=3^Drug Phototoxic Response
 ;;^UTILITY(U,$J,358.3,39012,1,4,0)
 ;;=4^L56.0
 ;;^UTILITY(U,$J,358.3,39012,2)
 ;;=^5009214
 ;;^UTILITY(U,$J,358.3,39013,0)
 ;;=L56.1^^152^1990^141
 ;;^UTILITY(U,$J,358.3,39013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39013,1,3,0)
 ;;=3^Drug Photoallergic Response
 ;;^UTILITY(U,$J,358.3,39013,1,4,0)
 ;;=4^L56.1
 ;;^UTILITY(U,$J,358.3,39013,2)
 ;;=^5009215
 ;;^UTILITY(U,$J,358.3,39014,0)
 ;;=L56.2^^152^1990^274
 ;;^UTILITY(U,$J,358.3,39014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39014,1,3,0)
 ;;=3^Photocontact Dermatitis
 ;;^UTILITY(U,$J,358.3,39014,1,4,0)
 ;;=4^L56.2
 ;;^UTILITY(U,$J,358.3,39014,2)
 ;;=^5009216
 ;;^UTILITY(U,$J,358.3,39015,0)
 ;;=L56.3^^152^1990^308
 ;;^UTILITY(U,$J,358.3,39015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39015,1,3,0)
 ;;=3^Solar Urticaria
 ;;^UTILITY(U,$J,358.3,39015,1,4,0)
 ;;=4^L56.3
 ;;^UTILITY(U,$J,358.3,39015,2)
 ;;=^5009217
 ;;^UTILITY(U,$J,358.3,39016,0)
 ;;=L57.0^^152^1990^13
 ;;^UTILITY(U,$J,358.3,39016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39016,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,39016,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,39016,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,39017,0)
 ;;=L60.0^^152^1990^164
 ;;^UTILITY(U,$J,358.3,39017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39017,1,3,0)
 ;;=3^Ingrowing Nail
 ;;^UTILITY(U,$J,358.3,39017,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,39017,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,39018,0)
 ;;=L60.1^^152^1990^272
 ;;^UTILITY(U,$J,358.3,39018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39018,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,39018,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,39018,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,39019,0)
 ;;=L60.2^^152^1990^271
 ;;^UTILITY(U,$J,358.3,39019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39019,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,39019,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,39019,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,39020,0)
 ;;=L60.3^^152^1990^176
